Correction of Vitamin D Deficiency Facilitated Suppression of IP-10 and DPP IV Levels in Patients with Chronic Hepatitis C: A Randomised Double-blinded, Placebo-control Trial

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Apr 5

PMID 28376103

Citations 18

Authors

Piyawat Komolmit

Kriangsak Charoensuk

Kessarin Thanapirom

Sirinporn Suksawatamnuay

Panarat Thaimai

Chintana Chirathaworn

Yong Poovorawan

Affiliations

Soon will be listed here.

Abstract

Trial Registration: Thai Clinical Trials Registry TCTR20160429001.

Citing Articles

Longitudinal associations between vitamin D status and biomarkers of inflammation in a pan-European cohort of children and adolescents.

Wolters M, Foraita R, Moreno L, Molnar D, Russo P, Tornaritis M Eur J Nutr. 2024; 63(8):3047-3060.

PMID: 39231874 PMC: 11519216. DOI: 10.1007/s00394-024-03488-7.

A review article on neuroprotective, immunomodulatory, and anti-inflammatory role of vitamin-D3 in elderly COVID-19 patients.

Tripathi A, Mishra S Egypt J Neurol Psychiatr Neurosurg. 2023; 59(1):18.

PMID: 36776226 PMC: 9901404. DOI: 10.1186/s41983-023-00611-z.

A Review on the Antiviral Activity of Functional Foods Against COVID-19 and Viral Respiratory Tract Infections.

Omer A, Khorshidi S, Mortazavi N, Rahman H Int J Gen Med. 2022; 15:4817-4835.

PMID: 35592539 PMC: 9112189. DOI: 10.2147/IJGM.S361001.

Vitamin D and its' role in Parkinson's disease patients with SARS-CoV-2 infection. A review article.

Azzam A, Ghozy S, Azab M Interdiscip Neurosurg. 2021; 27:101441.

PMID: 34868885 PMC: 8627384. DOI: 10.1016/j.inat.2021.101441.

The Association between Vitamin D and Zinc Status and the Progression of Clinical Symptoms among Outpatients Infected with SARS-CoV-2 and Potentially Non-Infected Participants: A Cross-Sectional Study.

Golabi S, Adelipour M, Mobarak S, Piri M, Seyedtabib M, Bagheri R Nutrients. 2021; 13(10).

PMID: 34684369 PMC: 8537338. DOI: 10.3390/nu13103368.

References

Charles E, Dustin L . Chemokine antagonism in chronic hepatitis C virus infection. J Clin Invest. 2010; 121(1):25-7. PMC: 3007165. DOI: 10.1172/JCI45610. View

Heim M, Thimme R . Innate and adaptive immune responses in HCV infections. J Hepatol. 2014; 61(1 Suppl):S14-25. DOI: 10.1016/j.jhep.2014.06.035. View

Liu N, Nguyen L, Chun R, Lagishetty V, Ren S, Wu S . Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology. 2008; 149(10):4799-808. PMC: 2582909. DOI: 10.1210/en.2008-0060. View

Tu Z, Hamalainen-Laanaya H, Nishitani C, Kuroki Y, Crispe I, Orloff M . HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation. Int Immunol. 2011; 24(2):97-106. DOI: 10.1093/intimm/dxr104. View

Hewison M . Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am. 2010; 39(2):365-79, table of contents. PMC: 2879394. DOI: 10.1016/j.ecl.2010.02.010. View

Kondo Y, Kato T, Kimura O, Iwata T, Ninomiya M, Kakazu E . 1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial. PLoS One. 2013; 8(5):e63672. PMC: 3662784. DOI: 10.1371/journal.pone.0063672. View

Yusupov E, Li-Ng M, Pollack S, Yeh J, Mikhail M, Aloia J . Vitamin d and serum cytokines in a randomized clinical trial. Int J Endocrinol. 2010; 2010. PMC: 2943086. DOI: 10.1155/2010/305054. View

. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015; 62(3):932-54. DOI: 10.1002/hep.27950. View

Shields P, Morland C, Salmon M, Qin S, Hubscher S, Adams D . Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol. 1999; 163(11):6236-43. View

10.

Romero A, Lagging M, Westin J, Dhillon A, Dustin L, Pawlotsky J . Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis. 2006; 194(7):895-903. DOI: 10.1086/507307. View

11.

Lagging M, Romero A, Westin J, Norkrans G, Dhillon A, Pawlotsky J . IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology. 2006; 44(6):1617-25. DOI: 10.1002/hep.21407. View

12.

Wang T, Zhang F, Richards J, Kestenbaum B, van Meurs J, Berry D . Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010; 376(9736):180-8. PMC: 3086761. DOI: 10.1016/S0140-6736(10)60588-0. View

13.

Joshi S, Pantalena L, Liu X, Gaffen S, Liu H, Rohowsky-Kochan C . 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol. 2011; 31(17):3653-69. PMC: 3165548. DOI: 10.1128/MCB.05020-11. View

14.

Lauer G, Walker B . Hepatitis C virus infection. N Engl J Med. 2001; 345(1):41-52. DOI: 10.1056/NEJM200107053450107. View

15.

Lange C, Bibert S, Kutalik Z, Burgisser P, Cerny A, Dufour J . A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. PLoS One. 2012; 7(7):e40159. PMC: 3395683. DOI: 10.1371/journal.pone.0040159. View

16.

Bitetto D, Fattovich G, Fabris C, Ceriani E, Falleti E, Fornasiere E . Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology. 2011; 53(4):1118-26. DOI: 10.1002/hep.24201. View

17.

Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, Vallet-Pichard A . Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest. 2010; 121(1):308-17. PMC: 3007131. DOI: 10.1172/JCI40594. View

18.

Dill M, Duong F, Vogt J, Bibert S, Bochud P, Terracciano L . Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. Gastroenterology. 2010; 140(3):1021-31. DOI: 10.1053/j.gastro.2010.11.039. View

19.

Falleti E, Bitetto D, Fabris C, Fattovich G, Cussigh A, Cmet S . Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology. 2012; 56(5):1641-50. DOI: 10.1002/hep.25848. View

20.

Bengsch B, Seigel B, Flecken T, Wolanski J, Blum H, Thimme R . Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26). J Immunol. 2012; 188(11):5438-47. DOI: 10.4049/jimmunol.1103801. View